Insmed Launches Brinsupri Tablets in Japan for Bronchiectasis
Insmed launched Brinsupri tablets, 25 mg, in Japan for the treatment of non-cystic fibrosis bronchiectasis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Insmed launches BRINSUPRI tablets in Japan
Insmed launched BRINSUPRI 25 mg tablets (brensocatib hydrate) for non-cystic fibrosis bronchiectasis in Japan.